The Scientific Research Team at Iktos leverages advanced artificial intelligence and deep learning generative models to drive innovation in medicinal chemistry and new drug design. The team, consisting of experts in computational chemistry, data science, and organic chemistry, collaborates to develop and optimize molecules in silico, enhancing productivity in upstream pharmaceutical R&D. Through the innovative use of Iktos's proprietary platforms, Makya™ and Spaya™, the team focuses on multi-parametric optimization and synthesis planning, ultimately accelerating the discovery of successful lead compounds.
View all